Watchlist Price Alert

Cardio Diagnostics Inc. (CDIO)

NASDAQ: CDIO · Real-Time Price · USD

4.23

0.24 (6.02%)

At close: Jun 02, 2025, 3:59 PM

4.24

0.24%

After-hours: Jun 02, 2025, 07:46 PM EDT

6.02% (1D)

Bid	3.9
Market Cap	7.35M
Revenue (ttm)	19.9K
Net Income (ttm)	-5.85M
EPS (ttm)	-4.34
PE Ratio (ttm)	-0.97
Forward PE	-0.24
Analyst	Hold

Ask	4.41
Volume	38,045
Avg. Volume (20D)	51,337
Open	4.02
Previous Close	3.99
Day's Range	4.02 - 4.31
52-Week Range	3.40 - 53.10
Beta	3.64

About CDIO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CDIO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CDIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 weeks ago

-47.09%

Cardio Diagnostics Holdings shares are trading low... Unlock content with Pro Subscription

News

4 days ago · businesswire.com

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced it has regained compliance with Nasdaq minimum bid price.

1 week ago · businesswire.com

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics has the continued expansion of its reach with a new cohort of healthcare practices across the United States.

3 weeks ago · businesswire.com

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.

2 months ago · businesswire.com

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC's 74th Annual Scientific Session & Expo.